Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment.
Gelé T, Chéret A, Castro Gordon A, Nkam L, Furlan V, Pallier C, Becker PH, Catalan P, Goujard C, Taburet AM, Gasnault J, Gouget H, Barrail-Tran A.
Gelé T, et al. Among authors: furlan v.
J Antimicrob Chemother. 2021 Nov 12;76(12):3280-3285. doi: 10.1093/jac/dkab334.
J Antimicrob Chemother. 2021.
PMID: 34508640